Leflunomide-associated progressive multifocal leukoencephalopathy

Archives of Neurology

Volumn 65, Issue 11, 2008, Pages 1538-1539

  Rahmlow, Megan ^b   Shuster, Elizabeth A ^b   Dominik, Jacob ^b   Deen Jr , H Gordon ^b   Dickson, Dennis W ^b   Aksamit Jr , Allen J ^b   Robles, Hector A ^b   Freeman, William D ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYTARABINE; ETIRACETAM; LEFLUNOMIDE; PHENYTOIN;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; GRAND MAL SEIZURE; HUMAN; JC VIRUS; MALE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RHEUMATOID ARTHRITIS; SYMPTOM;

ARTHRITIS, RHEUMATOID; BIOPSY; BRAIN; CYTARABINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; ISOXAZOLES; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SEIZURES; STAINING AND LABELING;

EID: 55949099918     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.11.1538     Document Type: Article

References (4)

1. Koralnik IJ. Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name? Ann Neurol. 2006;60(2):162-173.
2. Warnatz K, Peter HH, Schumacher M, et al. Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature. Ann Rheum Dis. 2003;62(1):50-57.
3. Yousry TA, Major EO, Ryschkewitsch C, et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med. 2006;354(9):924-933.
4. Yiannoutsos CT, Major EO, Curfman B, et al. Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy. Ann Neurol. 1999;45(6):816-821.